Concepedia

Nikunj Satani

NS

Statistics

Publications

19

Citations

3.1K

H-Index

13

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Henry Ford Hospital

Harvard University

Beth Israel Deaconess Medical Center

Nikunj Satani is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and life sciences.

Publications per year

2016–2022

19

Publications

19

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment

Qianghu Wang, Baoli Hu, Xin Hu et al. · Cancer Cell · 2017 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +16

Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer

Prasenjit Dey, Joelle Baddour, Florian L. Müller et al. · Nature · 2017 · 270 citations · Full text

Medicine, Genetics, Oncology +9

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Rina M. Mbofung, Jodi A. McKenzie, Shruti Malu et al. · Nature Communications · 2017 · 156 citations · Full text

Life Sciences, Immunology, Oncology +17

An enolase inhibitor for the targeted treatment of ENO1-deleted cancers

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi et al. · Nature Metabolism · 2020 · 103 citations · Full text

Medicine, Cancer Biology, Oncology +4

SF2312 is a natural phosphonate inhibitor of enolase

Paul G. Leonard, Nikunj Satani, David S. Maxwell et al. · Nature Chemical Biology · 2016 · 102 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +4

1–5 of 19